Dr. Mildvan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Beth Israel Med Ctr, Div Infectious Dis
New York, NY 10003- Is this information wrong?
Summary
- Dr. Donna Mildvan is an infectious disease specialist in New York, NY. She received her medical degree from Johns Hopkins University School of Medicine. She consults in hiv/aids medicine and infectious diseases and is experienced in hepatitis c, vaccines, and anti-hiv agents.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1970 - 1972
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1968 - 1970
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1967 - 1968
- Johns Hopkins University School of MedicineClass of 1967
Certifications & Licensure
- NY State Medical License 1969 - 2025
- MD State Medical License 1970 - 1997
- CA State Medical License 1972 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Infectious Disease Specialist US News World Report Doctors
- America's Top Doctors Castle Connolly
- Top Doctors New York Metro Area Castle Connolly
- Join now to see all
Clinical Trials
- A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
- Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation Start of enrollment: 2006 Mar 01
- Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsBehavioral Intervention Improves Treatment Outcomes Among HIV-Infected Individuals Who Have Delayed, Declined, or Discontinued Antiretroviral Therapy: A Randomized Con...Marya Gwadz, Charles M. Cleland, Elizabeth Applegate, Mindy Belkin, Monica Gandhi, Nadim Salomon, Angela Banfield, Noelle R. Leonard, Marion Riedel, Hannah Wolfe, Isai...> ;Aids and Behavior. 2015 Apr 3
- 20 citationsHIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts.Marya Gwadz, Elizabeth Applegate, Charles M. Cleland, Noelle R. Leonard, Hannah Wolfe, Nadim Salomon, Mindy Belkin, Marion Riedel, Angela Banfield, Lisa Sanfilippo, An...> ;Frontiers in Public Health. 2014 Jul 16
- 15 citationsACT2 peer-driven intervention increases enrollment into HIV/AIDS medical studies among African Americans/Blacks and Hispanics: A cluster randomized controlled trial.Marya Gwadz, Charles M. Cleland, Mindy Belkin, Amanda S. Ritchie, Noelle R. Leonard, Marion Riedel, Angela Banfield, Pablo Colon, Vanessa Elharrar, Jonathan C. Kagan, ...> ;Aids and Behavior. 2014 Jun 25
- Join now to see all
Press Mentions
- Differences in Immune Response May Explain Why HIV-1 Disease Progresses Faster in Women Than in Men with Same Viral LoadJuly 13th, 2009
Grant Support
- Adult Therapeutic Clinical Trials Program In AIDSNational Institute Of Allergy And Infectious Diseases2000–2008
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
- Mount Sinai Beth IsraelNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: